These findings are consistent with those of a recent report that TRPM7 overexpression was significantly higher in renal cell carcinoma clinical samples and RCC cancer cell lines, and this was positively correlated with tumor stages and worse overall survival and progression-free survival among RCC patients [25]. This evidence concerns the gene TRPM7 and neoplasm.